Team explains how stiffness in breast tissue contributes to invasive carcinoma

June 16, 2014
Mammary epithelial tissue structures undergo characteristic changes as tumors progress from benign to invasive. These human breast cancer tissue samples illustrate the difference. The scale bar is 50 microns. Credit: Ovijit Chaudhuri, Harvard University.

A team of researchers led by David J. Mooney, Robert P. Pinkas Family Professor of Bioengineering at the Harvard School of Engineering and Applied Sciences, have identified a possible mechanism by which normal cells turn malignant in mammary epithelial tissues, the tissues frequently involved in breast cancer.

Dense mammary tissue has long been recognized as a strong indicator of risk for breast cancer. This is why regular breast examinations are considered essential to early detection. Until now, however, the significance of that tissue density has been poorly understood.

By isolating mechanical and biological variables one by one in vitro, Mooney and his research team have discovered how the physical forces and chemical environment in those dense tissues can drive into a dangerously invasive, proliferating mode. The findings were published online June 15 in Nature Materials.

"While genetic mutations are at the root of cancer, a number of studies over the last 10 to 20 years have implicated the cellular microenvironment as playing a key role in promoting or suppressing tumor progression," says lead author Ovijit Chaudhuri, a former postdoctoral fellow in the Mooney Lab at Harvard who recently joined the mechanical engineering faculty at Stanford University. The new research finds that the stiffness of the extracellular matrix and the availability of certain ligands (molecules that bind to cell membranes) can together determine which genes are actually called on—and whether normal epithelial cells begin to exhibit the behaviors characteristic of highly malignant cancer cells. "Our findings suggest that evaluating the composition of this microenvironment, in addition to mammographic density, could potentially provide a better assessment of risk," Chaudhuri says.

Research in the Mooney Laboratory explores how the physical properties of natural biomaterials and synthetic polymers can affect how cells sense their environment, react to it, and signal to one another. The extracellular matrix—the complex network of crosslinked proteins and polymers that connects living cells to one another and facilitates communication between them—offers a challenging subject for study. The usual two-dimensional culture of cells on petri dishes has proven to be a poor model of three-dimensional tissues.

"As bioengineers, we can now design 3D culture systems where environmental parameters such as composition, porosity, and stiffness can be precisely tuned to study the importance of these cues on tumorigenesis," says coauthor Sandeep Koshy, a Harvard graduate student in the Harvard-MIT Program in Health Sciences and Technology, who works in Mooney's lab at Harvard SEAS and at the Wyss Institute for Biologically Inspired Engineering. "We're seeing that some of these factors have a major impact on cell behavior that is not possible to observe in conventional 2D cell cultures."

This diagram shows a cell encapsulated in an interpenetrating network of alginate (blue) and reconstituted basement membrane matrix (green). Integrin receptors on the cell membrane bind to ligands in the extracellular matrix. The alginate network stiffens the matrix without creating new biochemical bonds so that the researchers can study stiffness in isolation. Credit: Ovijit Chaudhuri, Harvard University.

Prior studies have used varying amounts of a fibrous protein called collagen to adjust the stiffness of the extracellular matrix, but Mooney's team recognized early on that collagen has more than a simple mechanical effect on cells: it can also trigger certain signaling pathways. Fibrous collagen is not normally found in the that surrounds the mammary epithelium, so any collagen signaling could confound the conclusions of those studies.

To eliminate uncontrolled variables, the team designed a new material model that uses alginate gel, instead of collagen, to stiffen the extracellular matrix without binding to any cell receptors. When this model was in its softest mode, normal (benign) mammary epithelial cells behaved normally within it, forming cellular structures referred to as acini that capture many key features of the normal in vivo mammary epithelium. But when the gel was stiffer, the cells began to upregulate the expression of cancer-related genes, and activity of the PI3K pathway that is known to drive cell proliferation and invasion increased.

"The invasive structures we observed in our stiff matrices resemble the morphology of early-stage invasive ductal carcinoma. They also show increased expression of the estrogen receptor alpha [ER+] gene that drives cell division," says Koshy. "It is striking that these changes, found in many human cancers, can be induced in normal mammary epithelial cells simply by varying the stiffness or composition of the matrix surrounding them."

But while stiffness is a key part of the story, it is not the full story. Further experiments indicated that the cells would recover their normal behavior in high-stiffness gels if they were exposed to increasing concentrations of laminin, a protein naturally found in the basement membrane.

When the extracellular matrix is very flexible, or when a high concentration of laminin is readily available, proteins called α6β4 integrins within the cell membrane bind with laminin to form small structures called hemidesmosomes, which anchor the epithelial cells to the basement membrane. But fluorescence microscopy revealed that the cells in a stiff matrix were not forming hemidesmosomes at all, so Mooney's team hypothesized that a stiffer matrix and a shortage of laminin was leaving the α6β4 integrins with dangling, unbound tails.

The Harvard researchers proposed a mechanism to explain how the stiffness and composition of the extracellular matrix could activate signaling pathways that produce a malignant phenotype. In normal conditions (left column), membrane components can fluctuate, overlap, and cluster, forming hemidesmosomes. In a stiffer matrix, they are unable to do so (center). The problem can be corrected in vitro by increasing the concentration of laminin (right). Credit: Ovijit Chaudhuri, Harvard University.

The team's final experiments demonstrated that these unbound integrin tails, indeed, get up to no good: they participate in the activation of two key biochemical pathways (PI3K and Rac1) that are necessary and sufficient to induce malignant cell behaviors in the in vitro epithelial tissue.

"If further studies validate that these processes are critical in human breast cancers," Koshy notes, "the possibility exists that agents that favorably modify the biophysical properties of the extracellular matrix, or that target the receptors and signaling molecules associated with how cells sense this matrix, could be used as a new avenue for the prevention or treatment of breast cancers."

In addition to the implications of this research for cancer biology, the development of the alginate-based model is also significant.

These confocal immunofluorescence images show how stiffness disrupts the formation of hemidesmosomes in the cell membranes of these epithelial cell clusters. At low stiffness, the components that form hemidesmosomes (red, pink, green, and cyan) behave normally (top row). Credit: Ovijit Chaudhuri, Harvard University

"Studies of many other biological processes could benefit from the use of this system," says Mooney, who in addition to his role at Harvard SEAS is also a Core Faculty Member at the Wyss Institute. "Studies on stem cell biology, wound healing, and development in a variety of tissues and organs could utilize this system."

Explore further: New clues to why older women are more vulnerable to breast cancer

More information: Paper: www.nature.com/nmat/journal/va … nt/abs/nmat4009.html

Related Stories

New clues to why older women are more vulnerable to breast cancer

June 5, 2014
Scientists from the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have gained more insights into why older women are more susceptible to breast cancer. They found that as women age, the cells ...

Seemingly invincible cancers stem cells reveal a weakness

June 5, 2014
Metastatic cancer cells, which can migrate from primary tumors to seed new malignancies, have thus far been resistant to the current arsenal of anticancer drugs. Now, however, researchers at Whitehead Institute have identified ...

Study identifies how signals trigger cancer cells to spread

May 25, 2014
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a signaling pathway in cancer cells that controls their ability to invade nearby tissues in a finely orchestrated manner. The findings ...

Biologists identify extracellular proteins that help aggressive tumors spread through the body

March 11, 2014
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold ...

Tiny oil droplets help measure mechanical forces produced by living cells that shape tissues and organs

December 9, 2013
(Phys.org) —As embryonic tissue develops, cells push and pull on each other, and they must do so correctly for the tissue to develop properly. Now scientists at Harvard University have devised the first method to measure ...

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.